PHARMASTRAT CONSULTING APS: Financial statements 2025
CVR: 43346318
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PHARMASTRAT CONSULTING APS (CVR 43346318) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -11,120 and a net result of DKK -29,821 compared with DKK -3,991 the year before. Equity in the 2025 report amounted to DKK 2,470,929. The solvency ratio was 94.5%.
- Gross Profit
- DKK -11,120
- Profit/Loss
- DKK -29,821
- Equity
- DKK 2,470,929
- Total Assets
- DKK 2,613,769
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -11K | -30K | 2.5M | 0 |
| 2024 | - | -15K | -4K | 2.6M | 0 |
| 2023 | - | -8K | 1.8M | 2.7M | - |
| 2022 | - | 260K | 25K | 907K | 0 |
Official annual report
How creditworthy is PHARMASTRAT CONSULTING APS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PHARMASTRAT CONSULTING APS has published its annual report for 2024. Gross profit came to DKK -14,613, and the net result was DKK -3,991.
About PHARMASTRAT CONSULTING APS
PHARMASTRAT CONSULTING APS is a Danish company of the type Anpartsselskab based in København SV, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Nicolas Clément Tipsmark Bouchet. The company is owned by Nicolas Clément Tipsmark Bouchet. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,120 and a net result of DKK -29,821 compared with DKK -3,991 the year before. Equity in the 2025 report amounted to DKK 2,470,929.